FDA.reportPublic FDA data

NDC 0143-9933-01 - Cefotaxime

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0143-9933
Requested NDC
0143-9933-01
Package NDCs from labels
0143-9933-01, 0143-9933-25
Manufacturer
Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
Effective date
2024-04-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefotaxime - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.AHikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A2024-04-11HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0143-9933-01Cefotaxime1 in 1 VIALINJECTION, POWDER, FOR SOLUTION114
0143-9933-25Cefotaxime25 in 1 PACKAGEINJECTION, POWDER, FOR SOLUTION2514

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0143-9933CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.]14Current NDC, Legacy NDC, 2 package rows20240413_ed23b6bc-32c7-4c50-a53d-313ae78e5623.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0143-9933-01EA - Each0143-993397d81e17-aac2-4896-8e5d-49be3dc5586b12013-10-17
0143-9933-22EA - Each0143-99334ee3ffdd-3e00-4c01-b658-f8393a7638a912013-02-11
0143-9933-25EA - Each0143-99333c03f405-f841-4626-804d-ae29ecb2086a12013-10-17

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFOTAXIME SODIUMACTIVE INGREDIENT258J72S7TZCEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP]10
CEFOTAXIMEACTIVE MOIETYN2GI8B1GK7CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP]10

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefotaximeCEFOTAXIME INJECTIONSteriMax Inc.8efe3bd0-c43a-2bd6-e053-2a95a90a92fa2026-06-15Exact identifier
rxcui: 1656313
rxcui: 1656318
unii: 258J72S7TZ
CefotaximeCEFOTAXIMEHikma Pharmaceuticals USA Inc.ed23b6bc-32c7-4c50-a53d-313ae78e56232024-04-11Warnings, Adverse reactionsExact identifier
application number: ANDA065072
ndc (package): 0143-9930-01
ndc (package): 0143-9931-01
ndc (package): 0143-9930-10
ndc (package): 0143-9933-01
ndc (package): 0143-9931-25
ndc (package): 0143-9933-25
ndc (product): 0143-9931
ndc (product): 0143-9930
ndc (product): 0143-9933
ndc11 (package): 00143993301
rxcui: 309068
rxcui: 1656313
rxcui: 1656318
spl id: 7e0897ec-2275-4438-9cc5-4c951e52ad97
spl set id: ed23b6bc-32c7-4c50-a53d-313ae78e5623
unii: 258J72S7TZ
CefotaximeCEFOTAXIMEHikma Pharmaceuticals USA Inc.ef1a6dc6-bc3d-4f09-8f92-7ff328f565612024-04-11Warnings, Adverse reactionsExact identifier
unii: 258J72S7TZ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.